Bristol-Myers Squibb Co (NYSE:BMY)
$ 44.94 0.2 (0.45%) Market Cap: 91.10 Bil Enterprise Value: 138.84 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 83/100

Bristol-Myers Squibb Co at Sanford C Bernstein Strategic Decisions Conference Transcript

Jun 02, 2022 / 12:00PM GMT
Release Date Price: $75.07 (+0.15%)
Wimal Kapadia
Sanford C. Bernstein & Co., LLC., Research Division - Research Analyst

Good morning, everybody, and thank you for joining today. I'm Wimal Kapadia, the EU biopharma analyst here at Bernstein. It's my great pleasure to introduce Giovanni Caforio, CEO of Bristol-Myers Squibb; and Samit Hirawat, Chief Medical Officer at BMS. Thank you for your time. We really appreciate it.

Giovanni Caforio
Bristol-Myers Squibb Company - Chairman of the Board & CEO

Thanks, Wimal.

Wimal Kapadia
Sanford C. Bernstein & Co., LLC., Research Division - Research Analyst

(Operator Instructions) And it's nice to see we've already got a few questions submitted, so thank you very much. I think with that, we can kick off. And I think, Giovanni, we'll sort of jump straight into Q&A if that works.

Giovanni Caforio
Bristol-Myers Squibb Company - Chairman of the Board & CEO

That's perfect, thank you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot